Pharmaceutical Anti-Counterfeiting Costs Eli Lilly Over $100 Million

Back to NAM Blog

Pharmaceutical Anti-Counterfeiting Costs Eli Lilly Over $100 Million

Earlier this month, it was announced that pharmaceutical giant Eli Lilly was investing more than $100 million to combat drug counterfeiting - $110 million, to be exact. The company is hoping to stump counterfeiters by stamping serial numbers and unique codes on every single drug package sold around the globe, making the drugs traceable according to a recent article at Fiercepharma.com. One of the most counterfeited drugs manufactured by Lilly is Cialis, the drug designed for erectile dysfunction. Lilly is set to work on implementing the new pharmaceutical anti-counterfeiting system over the next two years, which is when most of the $110 million will be spent. The Indianapolis-based company already spends millions in efforts to combat counterfeiting of their products. In 2015, a new law mandates that drug makers will be required to start tracking prescription drug lots; the program implemented by Lilly will position the company well as the new track-and-trace program is rolled out by the U.S. next year. As illegal drug operations are growing more sophisticated all the time, Lilly has been the victim on numerous occasions. John Lechleiter, Lilly's Chief Executive Officer, made anti-counterfeiting one of the company's top priorities. Today, Lilly staffs a team of drug investigators who are located on three continents. Lilly understands how critical it is to crack down on counterfeiters, as some now target drugs which are potentially life-saving for patients with heart conditions, cancer, and other potentially fatal conditions. This puts patients' lives at risk, not to mention company brands. At Markem-Imaje, we know that in coming months we will see more and more pharmaceutical companies developing systems to reduce or eliminate drug counterfeiting. As a trusted world-wide leader in industrial traceability solutions, we are ready to do our part! Contact Markem-Imaje for all of your industrial printing, coding/marking, and traceability needs.

January 10, 2014
Markem-Imaje Announces Acquisition of CSAT

Markem-Imaje Announces Acquisition of CSAT
Back to top